Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

European Physician Survey of EGFR Inhibitor Prescribing Patterns

This study has been completed.
Information provided by (Responsible Party):
Amgen Identifier:
First received: June 5, 2012
Last updated: February 29, 2016
Last verified: February 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2014
  Primary Completion Date: November 2014 (Final data collection date for primary outcome measure)